Form 8-K - Current report:
SEC Accession No. 0001564590-19-042154
Filing Date
2019-11-08
Accepted
2019-11-08 14:00:53
Documents
17
Period of Report
2019-11-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20191108.htm   iXBRL 8-K 45979
2 EX-99.1 fgen-ex991_6.htm EX-99.1 54337
3 GRAPHIC gqhynqe2gimc000003.jpg GRAPHIC 17021
4 GRAPHIC gqhynqe2gimc000002.jpg GRAPHIC 15697
5 GRAPHIC gqhynqe2gimc000001.jpg GRAPHIC 4406
6 GRAPHIC gqhynqe2gimc000004.jpg GRAPHIC 15906
  Complete submission text file 0001564590-19-042154.txt   311309

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191108.xsd EX-101.SCH 5968
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191108_lab.xml EX-101.LAB 18734
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191108_pre.xml EX-101.PRE 11175
12 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20191108_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191203499
SIC: 2834 Pharmaceutical Preparations